Amidst huge demand for essential medicines due to rising cases of COVID-19 across the country, the Centre is undertaking measures to ramp up production and availability of drugs.

The Government is pro-actively working to speed up the production of essential medicines to avoid any drug crisis-like situation during the nationwide lockdown owing to the Coronavirus (COVID-19) pandemic that has claimed over 390 lives in the country so far, an official said.

The process of manufacturing drugs has been made easier, the official was quoted as saying by a IANS report.

For this, the Ministry of Environment, Forest and Climate Change has amended the Environmental Impact Assessment (EIA) Notification 2006 following which all projects of drugs manufactured for the treatment of all diseases have been re-classified from the existing ‘A’ category to ‘B2’ category.

Projects falling in the ‘B2’ category have been exempted from the collection of baseline data, environmental impact assessment (EIA) studies and the need for public consultation.

This will now allow them to be evaluated at the state level which will accelerate the manufacturing as well as production of medicines.

The government has taken this step with the objective of increasing the availability of essential medicines in the country.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.